FDA and European Medicines Agency Agree to Accept a Single Orphan Drug Designation Annual Report
By Frontier India Pharmacetuicals News | February 27th, 2010 | Category: Europe Medical News, U.S Medical news | No Comments »In recognition of World Rare Disease Day, the U.S. Food and Drug Administration and the European Medicines Agency (EMA) today announced a more streamlined process to help regulators better identify and share information throughout the development process of orphan drug and biologic products, which are developed specifically to treat rare medical conditions. Both agencies have [...]